The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

Rossen Reports looked at the FTC data so far in 2024. Read the full story here. Millions of us have memberships to wholesale ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

Medicare Advantage denials. Medicare Advantage plans, which are private insurance plans that contract with Medicare, denied 3 ...

When Brad Jacobsen, a retired St. Paul police officer, was informed by his doctor at Regions Hospital that his November medical appointment would have to be rescheduled, he asked for a date early next ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...